Immunohistochemical examination of the tolerance -inducing enzyme indoleamine 2,3 -dioxygenase ( IDO ) in melanoma as a prognostic marker for progression-free- and overall survival
- Conditions
- C43Malignant melanoma of skin
- Registration Number
- DRKS00010682
- Lead Sponsor
- niversitätsklinik FreiburgDermatologie und Venerologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
available paraffin sections from patients with melanoma +/- sentinel lymph node with tumor thicknesses of less than 1 mm , greater than or equal 4mm and metastasis of melanoma of unknown primary
Exclusion Criteria
none
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is the correlation of the expression of the parameters with the progression-free and overall survival
- Secondary Outcome Measures
Name Time Method